drug: levodopa
- Clinical class: Anti-Parkinsonian
- Chemical class: aromatic amino acid
- Action: dopamine precursor
- CSA schedule: none
- DEA number: none
- Also: L-dopa
U.S. Preparations:
- Atamet (combination with carbidopa; Athena) FDA approved indications: treatment of idiopathic Parkinson's disease, postencephalitic Parkinsonism and Parkinsonism which may follow toxic injury
- Carbidopa /Levodopa Tablets, USP
- Dopar (Roberts) FDA approved indications: treatment of idiopathic Parkinson's disease, postencephalitic Parkinsonism and Parkinsonism which may follow toxic injury
- Larodopa (Roche Pharmaceuticals) FDA approved indications: treatment of idiopathic Parkinson's disease, postencephalitic Parkinsonism and Parkinsonism which may follow toxic injury
- Sinemet® (combination with carbidopa)
- Sinemet® CR (combination with carbidopa)
- Stalevo™ (Novartis) combination with carbidopa and entacapone
Preparations Outside U.S.:
- Aktipar, Apo-Levocarb, Carbilev, Ceredopa, Dopaflex, Doparkin, Duellin, Eldopal, Isicom, Kardopal, Kinson (combination with levodopa; Alphapharm), Madopar, Madopark, Nacom, Nakom, Prolopa, Sinacarb, Sindopa, Striaton, Syndopa, Zimox